abstract |
The present invention relates to compositions containing such compounds which act as macrocyclic compounds and kinase inhibitors, in particular RIP2 and / or mutants thereof, for use in the diagnosis, prevention and / or treatment of RIP2-kinase related diseases . The present invention provides methods for use, for example, as pharmaceuticals or diagnostic reagents. |